[Intravenous proton-pump inhibitor for acute peptic ulcer bleeding--is profound acid suppression beneficial to reduce the risk of rebleeding?].

@article{Garrido2008IntravenousPI,
  title={[Intravenous proton-pump inhibitor for acute peptic ulcer bleeding--is profound acid suppression beneficial to reduce the risk of rebleeding?].},
  author={Antonio Garrido and Alvaro Gir{\'a}ldez and Roberto Mart{\'i}nez Trigo and E Ondrovic Leo and Alvaro F. Nieto Guil and Jos{\'e} Luis Brotons M{\'a}rquez},
  journal={Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva},
  year={2008},
  volume={100 8},
  pages={
          466-9
        }
}
OBJECTIVE To compare two regimens of pantoprazole administered intravenously in patients with ulcerative gastrointestinal bleeding (UGB), and a high risk of presenting with persitent or recurrent hemorrhage. MATERIAL AND METHOD Patients were randomized into two groups: group 0--treatment with a 80 mg bolus of pantoprazole administered intravenously, followed by continuous infusion of 8 mg/h for 72 hours; group 1--treatment with 40 mg of pantoprazole administered intravenously on a daily basis… CONTINUE READING